← Ishga qaytish
Ushbu ishga iqtibos qilgan ishlar
2 ta ish
Ish: Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity
Ashot Avagimyan, А. И. Трофименко, Mohammad Sheibani +11
MaqolaOchiq kirishChemotherapy-induced cardiotoxicity and mitigationInnovative medicine of Kuban20231 iqtibosABI